PURPOSE: To demonstrate an MRI method for directly visualizing amyloid-beta (Abeta) plaques in the APP/PS1 transgenic (tg) mouse brain in vivo, and show that T1rho relaxation rate increases progressively with Alzheimer's disease (AD)-related pathology in the tg mouse brain. MATERIALS AND METHODS: We obtained in vivo MR images of a mouse model of AD (APP/PS1) that overexpresses human amyloid precursor protein, and measured T1rho via quantitative relaxometric maps. RESULTS: A significant decrease in T1rho was observed in the cortex and hippocampus of 12- and 18-month-old animals compared to their age-matched controls. There was also a correlation between changes in T1rho and the age of the animals. CONCLUSION: T1rho relaxometry may be a sensitive method for noninvasively determining AD-related pathology in APP/PS1 mice. Copyright (c) 2006 Wiley-Liss, Inc.
PURPOSE: To demonstrate an MRI method for directly visualizing amyloid-beta (Abeta) plaques in the APP/PS1 transgenic (tg) mouse brain in vivo, and show that T1rho relaxation rate increases progressively with Alzheimer's disease (AD)-related pathology in the tg mouse brain. MATERIALS AND METHODS: We obtained in vivo MR images of a mouse model of AD (APP/PS1) that overexpresses humanamyloid precursor protein, and measured T1rho via quantitative relaxometric maps. RESULTS: A significant decrease in T1rho was observed in the cortex and hippocampus of 12- and 18-month-old animals compared to their age-matched controls. There was also a correlation between changes in T1rho and the age of the animals. CONCLUSION: T1rho relaxometry may be a sensitive method for noninvasively determining AD-related pathology in APP/PS1mice. Copyright (c) 2006 Wiley-Liss, Inc.
Authors: John F Reilly; Dora Games; Russell E Rydel; Stephen Freedman; Dale Schenk; Warren G Young; John H Morrison; Floyd E Bloom Journal: Proc Natl Acad Sci U S A Date: 2003-04-15 Impact factor: 11.205
Authors: S V Akella; R R Regatte; A J Gougoutas; A Borthakur; E M Shapiro; J B Kneeland; J S Leigh; R Reddy Journal: Magn Reson Med Date: 2001-09 Impact factor: 4.668
Authors: Dorothy G Flood; Andrew G Reaume; Karen S Dorfman; Yin Guo Lin; Diane M Lang; Stephen P Trusko; Mary J Savage; Wim G Annaert; Bart De Strooper; Robert Siman; Richard W Scott Journal: Neurobiol Aging Date: 2002 May-Jun Impact factor: 4.673
Authors: Joseph F Poduslo; Thomas M Wengenack; Geoffry L Curran; Thomas Wisniewski; Einar M Sigurdsson; Slobodon I Macura; Bret J Borowski; Clifford R Jack Journal: Neurobiol Dis Date: 2002-11 Impact factor: 5.996
Authors: Mohammad Haris; Anup Singh; Kejia Cai; Christos Davatzikos; John Q Trojanowski; Elias R Melhem; Christopher M Clark; Arijitt Borthakur Journal: J Neurol Date: 2010-10-07 Impact factor: 4.849
Authors: E A Mellon; D T Pilkinton; C M Clark; M A Elliott; W R Witschey; A Borthakur; R Reddy Journal: AJNR Am J Neuroradiol Date: 2009-02-12 Impact factor: 3.825
Authors: Arijitt Borthakur; Matthew Sochor; Christos Davatzikos; John Q Trojanowski; Christopher M Clark Journal: Neuroimage Date: 2008-04-01 Impact factor: 6.556
Authors: Shafik N Wassef; John Wemmie; Casey P Johnson; Hans Johnson; Jane S Paulsen; Jeffrey D Long; Vincent A Magnotta Journal: Mov Disord Date: 2015-03-29 Impact factor: 10.338
Authors: Laurel O Sillerud; Nathan O Solberg; Ryan Chamberlain; Robert A Orlando; John E Heidrich; David C Brown; Christina I Brady; Thomas A Vander Jagt; Michael Garwood; David L Vander Jagt Journal: J Alzheimers Dis Date: 2013 Impact factor: 4.472
Authors: Kimmo T Jokivarsi; Juha-Pekka Niskanen; Shalom Michaeli; Heidi I Gröhn; Michael Garwood; Risto A Kauppinen; Olli H Gröhn Journal: J Cereb Blood Flow Metab Date: 2008-10-01 Impact factor: 6.200
Authors: Mohammad Haris; Erin McArdle; Matthew Fenty; Anup Singh; Christos Davatzikos; John Q Trojanowski; Elias R Melhem; Christopher M Clark; Arijitt Borthakur Journal: J Magn Reson Imaging Date: 2009-05 Impact factor: 4.813